Not a good buy right now for an impatient trader: price is in a clear downtrend and momentum is still deteriorating (bearish MA stack + negative/expanding MACD).
Stock is near support (around S2 ~7.05) and RSI is deeply washed out, so a short-term bounce is possible—but there is no Intellectia buy signal to prioritize and earnings on 2026-02-10 adds near-term event risk.
Options imply a large move (very high IV vs HV), which supports “wait for direction” rather than buying shares immediately.
Momentum: MACD histogram -0.0426 and negatively expanding → downside momentum is strengthening.
RSI: RSI_6 at 22.225 (washed-out/oversold condition), which can precede a rebound, but it is not a standalone buy signal while trend is bearish.
Levels: Current 7.17 is below S1 (7.407) and just above S2 (7.046). A break below ~7.05 risks further downside; reclaiming pivot ~7.99 is needed to improve the chart.
Pattern-based stats: modeled next-day expected move slightly negative (-0.14%), but next-month bias positive (+6.15%), suggesting any edge is more “bounce later” than “buy now.”
Positioning/Sentiment: OI put/call 0.92 is fairly balanced (slightly more calls than puts), not a strong fear or strong bullish read.
Volume: Put volume is 0 vs call volume 10, so today’s flow skews bullish, but total volume is very small (thin signal quality).
Volatility: IV_30d 85.2% vs historical vol 33.85% → options are pricing an outsized move (often into earnings), implying elevated event risk rather than a clean directional edge.
Catalyst timing: Earnings pre-market on 2026-02-10 likely explains the elevated IV.
Technical Summary
Sell
9
Buy
2
Positive Catalysts
can produce a reflex bounce if selling pressure eases.
Neutral/Negative Catalysts
Strong bearish trend and worsening downside momentum (MACD expanding negative; bearish MA stack).
Near-term earnings event risk with very high implied volatility (market pricing a big move; direction uncertain).
No recent news-driven positive catalyst; sentiment support is limited.
Institutional/behavioral signals: Hedge funds and insiders are described as Neutral (no supportive accumulation signal).
No recent congress trading data available (no influential buying signal to lean on).
Financial Performance
Latest quarter: 2026/Q1.
Revenue: 573.5M, up 184.33% YoY (very strong top-line growth).
Profitability: Net income -98.5M (still a loss), but improved vs prior year per provided YoY change; EPS -0.71 also improved YoY.
Margins: Gross margin 44.24%, up 1.19% YoY (incremental improvement, but not yet translating into profitability).
Takeaway: Growth is strong, but the company remains loss-making—market focus will likely be on the path to profitability and forward guidance at the upcoming earnings.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
2025-12-18: JPMorgan raised PT to $9 from $8, kept Neutral → mildly constructive but not a conviction call.
2025-11-25: TD Cowen cut PT to $11 from $14, kept Buy → still bullish, but expectations were reduced.
Wall Street pros: improving targets/maintained Buy (TD Cowen) and a raised PT (JPM) support upside potential.
Wall Street cons: mixed conviction (Neutral at JPM) and a meaningful target cut suggest uncertainty and tempered expectations near-term.
Wall Street analysts forecast LUXE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LUXE is 10 USD with a low forecast of 9 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast LUXE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LUXE is 10 USD with a low forecast of 9 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 7.350
Low
9
Averages
10
High
11
Current: 7.350
Low
9
Averages
10
High
11
JPMorgan
Neutral
maintain
$8 -> $9
AI Analysis
2025-12-18
Reason
JPMorgan
Price Target
$8 -> $9
AI Analysis
2025-12-18
maintain
Neutral
Reason
JPMorgan raised the firm's price target on LuxExperience to $9 from $8 and keeps a Neutral rating on the shares. The firm updated the company's model after meeting with management.
TD Cowen
Oliver Chen
Buy
downgrade
$14 -> $11
2025-11-25
Reason
TD Cowen
Oliver Chen
Price Target
$14 -> $11
2025-11-25
downgrade
Buy
Reason
TD Cowen analyst Oliver Chen lowered the firm's price target on LuxExperience to $11 from $14 and keeps a Buy rating on the shares. The firm updated its model to reflect recently published earnings.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LUXE
